* Q2 robot-assisted procedure growth in US slows to 12% * CEO David Rosa says coverage may delay elective treatments * Expired enhanced ACA premium subsidies had modest adverse impact in US in Q2,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)